[Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
The amino acid solution, Aminofusin hepar, was evaluated for treatment of hepatic encephalopathy and for parenteral nutrition of patients with liver cirrhosis in correlation to changes in amino acid levels. In contrast to amino acid solutions used for the parenteral nutrition of patients without liver disease, this solution contains an increased proportion of branch chained amino acids and of arginine and ornithine, and a reduced proportion of phenylalanine, methionine, glycine and threonine. The changes in the plasma amino acid levels after infusion of this solution were measured in 4 cirrhotics. The concentration of leucine, isoleucine, valine, ornithine and arginine increased markedly, whereas phenylalanine, methionine, tyrosine, glycine and threonine decreased. The ammonia level in venous blood increased slightly. 4 cirrhotics with encephalopathy were treated for 7 days. In 3 of them the neuropsychiatric symptoms were completely reversed, whereas in the remaining 1 no clinical improvement was achieved in spite of normalization of the plasma aminogramm. In this patient a constant rise of blood ammonia was noted. The indications for special amino acid solutions in liver diseases are discussed.
D000596:Amino Acids / Q000378:metabolism*; D000641:Ammonia / Q000097:blood; D001120:Arginine; D006501:Hepatic Encephalopathy / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000378:metabolism*; D009952:Ornithine; D010288:Parenteral Nutrition / Q000592:standards*
D000596:Amino Acids; D000641:Ammonia; D001120:Arginine; D009952:Ornithine
Parenterale Ernährung von Patienten mit Leberzirrhosé mit hepatischer Enzephalopathie.